Skip to content

Retrospective Study on Clinicopathologic Features and Prognosis of thoracic tumor

Retrospective Study on Clinicopathologic Features and Prognosis of thoracic tumor - Retrospective Study of thoracic tumor

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000031120
Enrollment
300
Registered
2018-02-02
Start date
2018-12-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest tumor which is represented by lung cancer, thymus epithelium tumor, and malignant pleural mesothelioma

Interventions

None listed

Sponsors

The Jikei Daisan Hospital, Japan
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patient who the diagnosis of chest tumor, an operation, chemotherapy, radiotherapy, relaxation care were carried out in the Jikei-Daisan Hospital until December 31, 2017.

Exclusion criteria

Exclusion criteria: The patients who refused to participate in our study.

Design outcomes

Primary

MeasureTime frame
To explore factors related with curative effect, convalescence, complications.

Countries

Japan

Contacts

Public ContactNaoki Takasaka

The Jikei Daisan Hospital, Japan Division of Respirology, Department of Internal Medicine

ms97-seki@jikei.ac.jp03-3480-1151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026